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Background: To determine the distribution of 
HBeAg in chronic hepatitis B patients from different 
regions of Pakistan. 
Methods:  In this study a total of 677 individuals 
infected with hepatitis B for a minimum period of 6 
months, were included in the study. The information 
like age, gender along with area of residence, were 
recorded in a proforma filled for each study subject. 
A 3 ml blood sample was taken from each person. 
HBsAg,HBeAg and Anti HBe testing was carried out 
by ELISA. 
Results: Out of 677 study subjects, 517 (76.4%) were 
males and 160 (23.6%) females with an overall mean 
age of 35.42 +12.4 years. HBeAg was positive in 66 
(9.7%) . All HBeAg positive cases were negative for 
Anti HBe.  HBeAg positivity was 9.4% in Punjab, 
14.8% in KPK, 4.89 % in Sindh, 8.3% in AJ & K and 
13.3% in Gilgit Baltistan. 
Conclusion: There was a male predominance 
among Hepatitis B virus infected patients .Maximum 
cases were between 20 to 50 years of age. HBeAg 
positive cases were significantly less as compared to 
HBeAg negative cases.  
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Introduction 
Hepatitis B virus infection is one of the major health 
problems in Pakistan. Lot of advances have been seen 
in the recent past regarding management of this 
infection. Hepatitis B e Antigen (HbeAg) status of 
hepatitis B infected person has a great role in 
management of hepatitis B, in the light of guidelines 
by American Association for Study of Liver Diseases 
(AASLD). Study of HBeAg status in a population can 
give us an idea about magnitude of the aggressive 
disease in that particular area, which would be 
beneficial for all concerned and decision makers for 
allocation of resources for the management of the 
patients, as well as for implementing the control/ 
preventive measures. It is a  global health problem and 
an estimated 257 million people are living with HBV 
infection (defined as hepatitis B surface antigen 
positive) worldwide.1 HBV is found in almost every 
region of the globe and is highly endemic in Asia, sub-
Saharan Africa, South America and the Middle East.2 
World Health Organization (WHO) has divided the 
world into areas of high (more than 8%), high 
intermediate (5-7%), low intermediate (2-4%) and low 
(less than 2%) endemic areas for HBV, based on 
Hepatitis B surface Antigen (HBsAg) prevalence 
rates.3 Being a chronic disease the risk of developing 
cirrhosis, hepatic decompensation, and hepatocellular 
carcinoma (HCC) is increased in carriers of HBV as 
compared to general public because 15% to 40% of 
HBV infected may develop serious sequelae during 
their lifetime.4 Life-long surveillance of HBV infected 
individuals is therefore, required through testing them 
repeatedly for HBV DNA and parameters like 
Hepatitis Be Antigen (HBeAg), antibodies to Hepatitis 
Be antigen (Anti HBe) and alanine aminotransferase 
(ALT). HBV infected persons are divided into various 
categories like active carriers, inactive carriers, and 
resolved HBV infection, based upon their HBeAg, Anti 
HBe serostatus, HBV DNA  load and ALT levels.5 
Presence of HBeAg in chronic HBV infection is 
generally associated with active viral replication and 
infectivity, whereas Anti HBe shows loss of infectivity 
and viral replication. Few exceptions are those patients 
with core/ pre-core mutations, where there is viral 
activity in the absence of detectable HBeAg.6 HBeAg is 
a surrogate marker for HBV and is used as an alternate 
to HBV DNA in decision making for treatment, in 
patients with HBeAg positive serostatus along with 
ALT level more than twice of the upper limit of the 
normal.7 In majority of cases the loss of HBeAg is 
associated with a decrease in levels of HBV DNA, 
Journal of Rawalpindi Medical College (JRMC); 2017;21(3): 201-204 
 202 
normalization of ALT and significant clinical 
improvement despite the presence of HbsAg.8 
The prevalence as well as severity of the disease is not 
uniform in all segments of society because of certain 
high risk groups, high prevalence of HDV co-infection 
in certain areas as well as difference of HBV 
genotypes.9 According to a nationwide survey 
compiled by Pakistan Medical Research Council, the 
prevalence of HBsAg is 2.5% in Pakistan. Therefore, in 
a country of 180 million people, there are 
approximately 4.25 million hepatitis B carriers.10 As 
HBeAg positivity indicates active disease, generally 
requiring treatment, testing for HBeAg in different 
areas can give us an idea about severity of the disease 
in that population. This information can help us in 
allocation of resources for prevention/ control 
measures.  
 
Patients and Methods  
Ethical approval of research ethics committee of 
Armed Forces Institute of Pathology (AFIP) 
Rawalpindi was obtained. Total 677 hepatitis B 
carriers (HBsAg positive for a minimum period of 6 
months), were included . Those, with HCV or HIV co-
infection, on immunosuppressive drugs, patients on 
antiviral therapy for HBV and those not willing for 
participation in study, were excluded. HbsAg,HBeAg 
and Anti HBe testing was carried out with enzyme 
linked immunosorbent assay (ELISA). Patients’ serum 
was incubated with horseradish peroxidase linked 
antibody for formation of antigen antibody complexes, 
the presence of which is detected by adding a 
substrate. The resulting change in colour was read 
calorimetrically with help of an ELISA micro plate 
reader. Positive and negative controls were run in each 
batch. 
Results 
HBsAg tested positive in all 677 cases. Majority 
(76.4%) were males. Mean age of the patients was 
35.42+12.4 years. HBeAg was positive in 66 (9.7%) out 
of 677 tested (Table 1) .The maximum study subjects 
446 (65.9%) were from Punjab (Table 2). All HbeAg 
positive cases were negative for Anti HBe.  
Table 2: Distribution of study population 
Area No(%) 
Punjab 446(65.9) 
Khyber Pakhtunkhwa 108(16) 
Sindh 62 (9.2) 
Azad Jammu & Kashmir 36(5.3) 
Baluchistan 10(1.5) 
Gilgit Baltistan  15(2.2) 
Table 1: HBeAg percentage positivity in 
different regions of Pakistan 






Punjab 446 42 9.4% 
Khyber 
Pakhtoonkhwa 
108 16 14.8% 
Sindh 62 3 4.89% 
Azad Jammu 
and Kashmir 
36 1 3.8% 
Balochistan 15 2 13.3% 
Gilgit Baltistan 10 2 20% 
Total 667 66 9.89% 
 
Discussion 
Pakistan generally is a male dominated society where 
men have a central role in the families, being mostly 
responsible for earning bread and butter for their 
home-mates. In this study, there was a male 
preponderance which might be due to the better access 
and opportunities for males to the testing and 
treatment facilities for HBV infected cases. This male 
predominance was also observed in different studies 
carried out by Ghani  et al, Khokhar et al and Khan et 
al.11-13 The age of HBV infected persons in this study 
ranged between 1 to 80 years, with a mean of 35.42 
years (SD+12.3). This was similar to a study conducted 
in Hong Kong by Yuen et al, in which the mean age of 
presentation was 38 years with an age range of 1 to 85 
years. 14 In both genders, the maximum cases were 
between 21 and 50 years. Similar result were seen in  
studies conducted by Khan et al  and Castolo et al. 13,15 
 This age distribution indicates ongoing acquisition of 
HBV peri-natally and during childhood and highlights 
the importance of complete and comprehensive 
childhood immunization coverage against HBV 
infection. The overall result indicates that maximum 
number of patients have this problem during the 
prime of their lives when they are supposed to be the 
most useful members of their families as well as the 
society. 
The maximum study subjects (446) were from 
province of Punjab followed by 108 from KPK 62 from 
Sindh, 36 from AJK, 15 from GB and 10 from 
Baluchistan. This region wise distribution of the cases 
in our study was logical keeping in view geography of 
the country, the population density in various regions 
and location of the testing laboratory. This study was 
carried out in northern Punjab, so the maximum cases 
were from this province. The next highest number was 
from the province of KPK, the boundaries of which are 
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common with the northern Punjab. The Sindh 
province is situated in the southern part of the country 
and it was difficult for the study subjects to report due 
the distances involved, as was the case in Balochistan, 
AJK and GB.  
A male preponderance was seen in all our regions 
under study including Punjab, Sindh, KPK, 
Baluchistan, AJK and GB., A similar male 
predominance was observed in various studies 
conducted in different areas of Punjab including 
Manzoor et al in 1997, Alam et al in 2007, Moosa et al 
in 2009 and Khan et al in 2011, in which males were 
more as compared to females. 16-18 This was also 
observed in patients from KPK as well and mentioned 
in a study conducted by Farooqi et al in Peshawar in 
2007. Out of 62 persons from Sindh, 57 (91.9%) were 
males and 5 (8.1%) were females.  19 This trend was 
also noticed in a study conducted by Aziz et al in 
Sindh in 201020. The total number of cases from AJK 
was 36, out of which 26 (72.2%) were males and 10 
(27.8%) females. A similar male to female ratio was 
also seen in a study conducted by Naz et al in 
Muzaffarabad in 2002.21 
The mean age of patients from Punjab was 35.46+12.9 
years,, 33.06+14.2 years for patients from KPK, 40 + 9.5 
years for AJK patients and 31+6.2 years for patients 
from Sindh, The lowest mean age for Sindhi patients 
can be understood due to the fact that the disease 
generally reported from Sind areas is relatively 
aggressive. The higher mean age of the patient from 
AJK needs to be further explored because of the 
limited number of patients from AJK in this study. 
The overall HBeAg positivity in our study was 9.7 % 
which is higher than 7.5% reported in neighboring 
India, and less than a study conducted in Southern 
China, where the HBeAg positivity was 18.5%. 22,23  
This difference was probably due to higher prevalence 
of HBV in Southern China. In another study conducted 
in Italy, an overall HBeAg positivity of 11% was noted 
which was close to our percentage. 24 In this Italian 
study the immigrant group had a much higher HBeAg 
positivity of 18 % as majority of them were from 
developing countries. In Bangladesh, the prevalence of 
HBeAg was found to be 19.2% which was higher as 
compared to our study.  25 Moreover, in this study it 
was established that the HBeAg positivity decreased 
with increasing age showing that sero-conversion 
occurs with advancing age. 
The percentage of positivity for HBeAg in Punjab 
(9.4%) was almost same as reported for all cases 
(n=677). It was however, higher (14.9%)   in cases from 
KPK.  The less positivity of HBeAg in Sindh (4.89%) 
might be incidental as the number of patients was low, 
otherwise areas of Sindh and adjoining Southern 
Punjab are well known for the aggressive nature of the 
disease.There was a lower percentage (3.8%) in cases 
from AJK but the total number of the patients was only 
26 which is too low a number to give any statistically 
significant results. The number of patients was also 
less in Baluchistan as well as for the patients from GB.  
These studies show that HBeAg positivity is different 
in different geographical areas. There was no previous 
study showing HBeAg distribution in different areas 
of Pakistan. This study can serve as base-line for future 
studies of the problem from different angles.  
 
Conclusion 
1. A male predominance was noted in this study. The 
maximum numbers of chronic hepatitis B carriers were 
found between 20 to 50 years.  
2. HBeAg positive cases were less as compared to 
what has been reported earlier.  
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